Advertisement
Australia markets close in 9 minutes

  • ALL ORDS

    7,837.50
    -100.00 (-1.26%)
     

  • ASX 200

    7,576.60
    -106.40 (-1.38%)
     

  • AUD/USD

    0.6540
    +0.0017 (+0.26%)
     

  • OIL

    84.04
    +0.47 (+0.56%)
     

  • GOLD

    2,350.00
    +7.50 (+0.32%)
     

  • Bitcoin AUD

    98,689.63
    +520.93 (+0.53%)
     

  • CMC Crypto 200

    1,389.37
    -7.17 (-0.51%)
     

  • AUD/EUR

    0.6096
    +0.0022 (+0.37%)
     

  • AUD/NZD

    1.0964
    +0.0007 (+0.06%)
     

  • NZX 50

    11,805.09
    -141.34 (-1.18%)
     

  • NASDAQ

    17,430.50
    -96.30 (-0.55%)
     

  • FTSE

    8,078.86
    +38.48 (+0.48%)
     

  • Dow Jones

    38,085.80
    -375.12 (-0.98%)
     

  • DAX

    17,917.28
    -171.42 (-0.95%)
     

  • Hang Seng

    17,705.21
    +420.67 (+2.43%)
     

  • NIKKEI 225

    37,956.60
    +328.12 (+0.87%)
     

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of CXO, BSTC, CIT, and EIDX Mergers

Rigrodsky & Long, P.A.
·2-min read

WILMINGTON, Del., Oct. 26, 2020 (GLOBE NEWSWIRE) --

Rigrodsky & Long, P.A. announces that it is investigating:

Concho Resources Inc. (NYSE: CXO) regarding possible breaches of fiduciary duties and other violations of law related to Concho Resources’ agreement to be acquired by ConocoPhillips. Under the terms of the agreement Concho Resources’ shareholders will receive 1.46 shares of ConocoPhillips’ common stock per share. To learn more about this investigation and your rights, visit: https://www.rigrodskylong.com/cases-concho-resources-inc.

BioSpecifics Technologies Corp. (NASDAQ GM: BSTC) regarding possible breaches of fiduciary duties and other violations of law related to BioSpecifics Technologies’ agreement to be acquired by Endo International plc. Under the terms of the agreement, BioSpecifics Technologies’ shareholders will receive $88.50 in cash per share. To learn more about this investigation and your rights, visit: https://www.rigrodskylong.com/cases-biospecifics-technologies-corp.

ADVERTISEMENT

CIT Group Inc. (NYSE: CIT) regarding possible breaches of fiduciary duties and other violations of law related to CIT Group’s agreement to be acquired by First Citizens BancShares, Inc. Under the terms of the agreement, CIT Group’s shareholders will receive 0.0620 of a share of First Citizens Bancshares’ common stock per share. To learn more about this investigation and your rights, visit: https://www.rigrodskylong.com/cases-cit-group-inc.

Eidos Therapeutics, Inc. (NASDAQ GS: EIDX) regarding possible breaches of fiduciary duties and other violations of law related to Eidos’ agreement to be acquired by BridgeBio Pharma, Inc. Under the terms of the agreement, Eidos’ shareholders will receive 1.85 shares of BridgeBio common stock or $73.26 in cash per share. To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-eidos-therapeutics-inc.

You may also contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or info@rl-legal.com.

Rigrodsky & Long, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.

Attorney advertising. Prior results do not guarantee a similar outcome.

CONTACT:

Rigrodsky & Long, P.A.
Seth D. Rigrodsky
Gina M. Serra
(888) 969-4242 (Toll Free)
(302) 295-5310
Fax: (302) 654-7530
info@rl-legal.com
https://rl-legal.com